Italia markets closed

Medtronic plc (MDT)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
82,00-0,29 (-0,35%)
Alla chiusura: 04:00PM EDT
82,00 0,00 (0,00%)
Dopo ore: 05:18PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente82,29
Aperto82,13
Denaro81,94 x 800
Domanda82,02 x 1000
Min-Max giorno81,87 - 82,74
Intervallo di 52 settimane68,84 - 91,00
Volume7.420.104
Media Volume6.129.280
Capitalizzazione107,53B
Beta (mensile su 5 anni)0,80
Rapporto PE (ttm)29,71
EPS (ttm)2,76
Prossima data utili23 mag 2024
Rendimento e dividendo (futuro)2,80 (3,40%)
Data ex dividendo28 giu 2024
Stima target 1A94,00
  • GlobeNewswire

    Gentherm Announces Dr. Ken Washington as New Independent Director

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company’s Board of Directors, effective October 2, 2023. Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE: MDT),

  • GlobeNewswire

    Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients

    Hypertension is the most common comorbidity in the pacemaker population, affecting over 70% of patients or approximately 750,000 people annually worldwideMedtronic plc and Orchestra BioMed have an exclusive strategic collaboration for global development and commercialization of BackBeat Cardiac Neuromodulation Therapy™ (CNT), now also known as Atrioventricular Interval Modulation (“AVIM”) therapy, for hypertensive pacemaker patientsBACKBEAT global pivotal study is expected to start before the en